Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Boehringer Ingelheim
Express Scripts
Mallinckrodt
Medtronic

Last Updated: August 15, 2022

Investigational Drug Information for PQR309


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug PQR309?

PQR309 is an investigational drug.

There have been 9 clinical trials for PQR309. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2017.

The most common disease conditions in clinical trials are Lymphoma, Triple Negative Breast Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are PIQUR Therapeutics AG, University Hospital, Basel, Switzerland, and Churchill Hospital.

There are fifteen US patents protecting this investigational drug and two hundred and thirty international patents.

Recent Clinical Trials for PQR309
TitleSponsorPhase
Study of Oral PQR309 in Patients With Advanced Solid TumorsCase Western Reserve UniversityPhase 1
Study of Oral PQR309 in Patients With Advanced Solid TumorsChurchill HospitalPhase 1
Study of Oral PQR309 in Patients With Advanced Solid TumorsHospital Clinic of BarcelonaPhase 1

See all PQR309 clinical trials

Clinical Trial Summary for PQR309

Top disease conditions for PQR309
Top clinical trial sponsors for PQR309

See all PQR309 clinical trials

US Patents for PQR309

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PQR309 See Plans and Pricing Manufacturing process for triazine, pyrimidine and pyridine derivatives UNIVERSITAET BASEL (Basel, CH) PIQUR THERAPEUTICS AG (Basel, CH) See Plans and Pricing
PQR309 See Plans and Pricing Uses of indolinone compounds Oncternal Therapeutics, Inc. (San Diego, CA) See Plans and Pricing
PQR309 See Plans and Pricing Compositions of CXCR4 inhibitors and methods of preparation and use X4 PHARMACEUTICALS, INC. (Cambridge, MA) See Plans and Pricing
PQR309 See Plans and Pricing Crystalline forms Array Biopharma Inc. (Boulder, CO) See Plans and Pricing
PQR309 See Plans and Pricing Compounds for treating cancer BICYCLERD LIMITED (Cambridge, GB) See Plans and Pricing
PQR309 See Plans and Pricing Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines PIQUR THERAPEUTICS AG (Basel, CH) UNIVERSITAT BASEL (Basel, CH) See Plans and Pricing
PQR309 See Plans and Pricing Uses of indolinone compounds Oncternal Therapeutics, Inc. (San Diego, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for PQR309

Drugname Country Document Number Estimated Expiration Related US Patent
PQR309 Australia AU2015250994 2034-04-22 See Plans and Pricing
PQR309 Brazil BR112016023811 2034-04-22 See Plans and Pricing
PQR309 Canada CA2944697 2034-04-22 See Plans and Pricing
PQR309 China CN106458968 2034-04-22 See Plans and Pricing
PQR309 European Patent Office EP3134388 2034-04-22 See Plans and Pricing
PQR309 Spain ES2713452 2034-04-22 See Plans and Pricing
PQR309 Israel IL248272 2034-04-22 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Boehringer Ingelheim
Express Scripts
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.